140 related articles for article (PubMed ID: 36544361)
1. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and
Cannaert A; Sparkes E; Pike E; Luo JL; Fang A; Kevin RC; Ellison R; Gerona R; Banister SD; Stove CP
ACS Chem Neurosci; 2020 Dec; 11(24):4434-4446. PubMed ID: 33253529
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
[TBL] [Abstract][Full Text] [Related]
4. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
[TBL] [Abstract][Full Text] [Related]
5. 5F-MDMB-PICA metabolite identification and cannabinoid receptor activity.
Truver MT; Watanabe S; Åstrand A; Vikingsson S; Green H; Swortwood MJ; Kronstrand R
Drug Test Anal; 2020 Jan; 12(1):127-135. PubMed ID: 31461219
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of Cumyl-Carboxamide Synthetic Cannabinoid New Psychoactive Substances (NPS) CUMYL-BICA, CUMYL-PICA, CUMYL-5F-PICA, CUMYL-5F-PINACA, and Their Analogues.
Longworth M; Banister SD; Boyd R; Kevin RC; Connor M; McGregor IS; Kassiou M
ACS Chem Neurosci; 2017 Oct; 8(10):2159-2167. PubMed ID: 28792725
[TBL] [Abstract][Full Text] [Related]
7. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA.
Angerer V; Franz F; Moosmann B; Bisel P; Auwärter V
Forensic Toxicol; 2019; 37(1):186-196. PubMed ID: 30636986
[TBL] [Abstract][Full Text] [Related]
8. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
[TBL] [Abstract][Full Text] [Related]
9. New synthetic cannabinoids carrying a cyclobutyl methyl side chain: Human Phase I metabolism and data on human cannabinoid receptor 1 binding and activation of Cumyl-CBMICA and Cumyl-CBMINACA.
Haschimi B; Grafinger KE; Pulver B; Psychou E; Halter S; Huppertz LM; Westphal F; Pütz M; Auwärter V
Drug Test Anal; 2021 Aug; 13(8):1499-1515. PubMed ID: 33788409
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.
Kevin RC; Lefever TW; Snyder RW; Patel PR; Fennell TR; Wiley JL; McGregor IS; Thomas BF
Forensic Toxicol; 2017; 35(2):333-347. PubMed ID: 28824730
[TBL] [Abstract][Full Text] [Related]
11. Structural characterization of the new synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
Bovens M; Bissig C; Staeheli SN; Poetzsch M; Pfeiffer B; Kraemer T
Forensic Sci Int; 2017 Dec; 281():98-105. PubMed ID: 29125990
[TBL] [Abstract][Full Text] [Related]
12. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
[TBL] [Abstract][Full Text] [Related]
13. [Determination of four amide synthetic cannabinoid isomers by ultra-high performance liquid chromatography-high resolution mass spectrometry].
Tang R; Wang J; Xiao T; Qin S; Jie Z; Zhang A
Se Pu; 2024 Jan; 42(1):84-91. PubMed ID: 38197209
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry.
Carlier J; Diao X; Scheidweiler KB; Huestis MA
Clin Chem; 2017 May; 63(5):1008-1021. PubMed ID: 28302730
[TBL] [Abstract][Full Text] [Related]
15. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.
Wohlfarth A; Castaneto MS; Zhu M; Pang S; Scheidweiler KB; Kronstrand R; Huestis MA
AAPS J; 2015 May; 17(3):660-77. PubMed ID: 25721194
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Characterization of a Systematic Library of Alkyl and Alicyclic Synthetic Cannabinoids Related to CUMYL-PICA, CUMYL-BUTICA, CUMYL-CBMICA, and CUMYL-PINACA.
Janssens LK; Ametovski A; Sparkes E; Boyd R; Lai F; Maloney CJ; Rhook D; Gerona RR; Connolly M; Liu H; Hibbs DE; Cairns EA; Banister SD; Stove CP
ACS Chem Neurosci; 2023 Jan; 14(1):35-52. PubMed ID: 36530139
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Synthetic Cannabinoid Metabolites in Human Blood in the Absence of Parent Compounds: A Stability Assessment.
Krotulski AJ; Bishop-Freeman SC; Mohr ALA; Logan BK
J Anal Toxicol; 2021 Feb; 45(1):60-68. PubMed ID: 32435808
[TBL] [Abstract][Full Text] [Related]
18. Cannabimimetic effects of abused indazole-carboxamide synthetic cannabinoid receptor agonists AB-PINACA, 5F-AB-PINACA and 5F-ADB-PINACA in mice: Tolerance, dependence and withdrawal.
Wilson CD; Hiranita T; Fantegrossi WE
Drug Alcohol Depend; 2022 Jul; 236():109468. PubMed ID: 35643039
[TBL] [Abstract][Full Text] [Related]
19. The chemistry and pharmacology of putative synthetic cannabinoid receptor agonist (SCRA) new psychoactive substances (NPS) 5F-PY-PICA, 5F-PY-PINACA, and their analogs.
Banister SD; Kevin RC; Martin L; Adams A; Macdonald C; Manning JJ; Boyd R; Cunningham M; Stevens MY; McGregor IS; Glass M; Connor M; Gerona RR
Drug Test Anal; 2019 Jul; 11(7):976-989. PubMed ID: 30838752
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo pharmacology of nine novel synthetic cannabinoid receptor agonists.
Marusich JA; Gamage TF; Zhang Y; Akinfiresoye LR; Wiley JL
Pharmacol Biochem Behav; 2022 Oct; 220():173467. PubMed ID: 36154844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
